Biotage AB (Biotage AB) Price-to-Tangible-Book

: 27.08 (As of Today)

View and export this data going back to 2010. Start your Free Trial

As of today (2024-04-19), Biotage AB's share price is $16.87. Biotage AB's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.62. Hence, Biotage AB's Price to Tangible Book Ratio of today is 27.08.

The historical rank and industry rank for Biotage AB's Price-to-Tangible-Book or its related term are showing as below:

BITGF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.95 Med: 20.56 Max: 54.54
Current: 26.78

During the past 13 years, Biotage AB's highest Price to Tangible Book Ratio was 54.54. The lowest was 2.95. And the median was 20.56.

BITGF's Price-to-Tangible-Book is ranked worse than
97.59% of 704 companies
in the Medical Devices & Instruments industry
Industry Median: 2.565 vs BITGF: 26.78

A closely related ratio is called PB Ratio. As of today, Biotage AB's share price is $16.87. Biotage AB's Book Value per Sharefor the quarter that ended in Dec. 2023 was $4.46. Hence, Biotage AB's P/B Ratio of today is 3.79.

Biotage AB Price-to-Tangible-Book Historical Data

The historical data trend for Biotage AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

25.15

19.44

55.64

21.79

19.26

Biotage AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book																21.79	14.32	29.48	21.02	19.26

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Biotage AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotage AB Price-to-Tangible-Book Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Biotage AB's Price-to-Tangible-Book falls into.

Biotage AB Price-to-Tangible-Book Calculation

Biotage AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	16.87	/	0.623
	=	27.08

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Biotage AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Biotage AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotage AB (Biotage AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

BIOT:Sweden 0GRP:UK PQX1:Germany

Address

Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03

Website

https://www.biotage.com

Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.